RGEN 138.9 (+8.1%)
US7599161095Medical Devices & InstrumentsMedical Instruments & Supplies

Repligen (RGEN) Stock Highlights

138.9 | +8.1%
2024-11-21 01:09:32
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The companys customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the companys revenue is generated in North America.

Statistics

Range Today
128.91 139.17
Volume Today 710.91K
Range 1 Year
113.5 211.13
Volume 1 Year 165.66M
Range 3 Year
110.45 300.23
Volume 3 Year 442.84M
Range 10 Year
19.02 327.32
Volume 10 Year 1.13B

Highlights

Market Capitalization 7.88B (mid)
Floating Shares 52.21M
Current Price 138.9
Price To Earnings -4.77K
Price To Revenue 13.27
Price To Book 3.96
Earnings Per Share -0.03
Payout Ratio 0%

Performance

Latest +8.1%
1 Month -4.52%
3 Months -9.37%
6 Months -19.07%
1 Year -8.67%
3 Years -51.16%
5 Years +61.31%
10 Years +502.34%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.